申请人:Goldfinch Bio., Inc.
公开号:US20200377505A1
公开(公告)日:2020-12-03
Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II).